How do I prepare a furosemide infusion for a 70‑kg adult, including the loading dose and continuous infusion rate?

Furosemide Infusion Preparation for a 70-kg Adult

For a 70-kg adult requiring continuous furosemide infusion, administer a loading dose of 40 mg IV over 1-2 minutes, followed immediately by a continuous infusion starting at 5-10 mg/hour, with a maximum rate of 40 mg/hour. 1

Loading Dose

• Give 40 mg IV furosemide as a slow push over 1-2 minutes 1
• If the patient was already on oral furosemide at home, use 1-2.5 times their home oral dose as the IV loading dose instead 2
• For furosemide-naive patients, start at the lower end (20-40 mg) 2

Continuous Infusion Preparation

Mix the furosemide properly to avoid precipitation:

• Add furosemide to Normal Saline (0.9% NaCl), Lactated Ringer's, or D5W only after adjusting the pH above 5.5 1
• Furosemide injection has a pH of approximately 9 and will precipitate at pH values below 7 1
• Never mix with acidic solutions (labetalol, ciprofloxacin, amrinone, milrinone) as this causes immediate precipitation 1
• Do not add to a running IV line containing acidic medications 1

Infusion Rate

• Start at 5-10 mg/hour (typical range per guidelines) 2
• Maximum rate: 4 mg/minute or 40 mg/hour 1
• The FDA label explicitly states controlled infusion should not exceed 4 mg/min 1

Practical Example for 70-kg Adult:

• Loading dose: 40 mg IV push over 1-2 minutes
• Infusion: Mix 250 mg furosemide in 250 mL NS (1 mg/mL concentration)
• Start infusion at 5-10 mL/hour (5-10 mg/hour)
• Titrate up based on response, not exceeding 40 mL/hour (40 mg/hour)

Evidence Supporting Continuous Infusion

Continuous infusion is superior to intermittent boluses in patients with severe heart failure. Research demonstrates that continuous infusion preceded by a loading dose produces 12-26% greater diuresis and 11-33% greater sodium excretion compared to intermittent boluses, despite using equivalent total doses 3. A subsequent study confirmed that continuous infusion yields significantly higher urine output (2,860 vs 2,260 mL/day) and sodium excretion (210 vs 150 mmol/day) with fewer ototoxic side effects 4.

The mechanism relates to maintaining steady therapeutic drug levels at the nephron rather than the peaks and troughs seen with bolus dosing 4.

Monitoring Requirements

• Measure electrolytes at least daily 2
• Monitor daily weights, intake/output, serum creatinine, and BUN 2
• Assess urine output at 2 hours post-initiation—this is sufficient to evaluate diuretic response and guide dose adjustments 5
• Watch for signs of ototoxicity, particularly with rapid infusion rates or renal impairment 1

Critical Safety Warnings

Ototoxicity risk increases with:

• Infusion rates exceeding 4 mg/minute 1
• Severe renal impairment 1
• Concomitant aminoglycosides or other ototoxic drugs 1
• Hypoproteinemia 1

Five patients in one study experienced reversible hearing loss with bolus injection but none with continuous infusion 4, reinforcing the safety advantage of controlled infusion rates.

Expect a mild rise in serum creatinine during effective decongestion—this typically returns to baseline after discharge and is not associated with worse outcomes 2.

Dose Escalation Strategy

If inadequate response after 2 hours of assessment 5:

• Increase infusion rate in increments (e.g., from 5 to 10 mg/hour, then to 20 mg/hour)
• Do not exceed 40 mg/hour maximum 1
• Consider adding a thiazide-type diuretic (metolazone 2.5-5 mg orally) for sequential nephron blockade if refractory 2